Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |